Caribou Biosciences, Inc. - Common Stock (CRBU)

CUSIP: 142038108

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock
Shares outstanding
92,189,700
Total 13F shares
37,003,216
Share change
-7,989
Total reported value
$58,834,815
Put/Call ratio
141%
Price per share
$1.59
Number of holders
121
Value change
-$1,171,712
Number of buys
45
Number of sells
49

Quarterly Holders Quick Answers

What is CUSIP 142038108?
CUSIP 142038108 identifies CRBU - Caribou Biosciences, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q4 2025

As of 31 Dec 2025, Caribou Biosciences, Inc. - Common Stock (CRBU) was held by 121 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,003,216 shares. The largest 10 holders included Pfizer Inc, VANGUARD GROUP INC, Kynam Capital Management, LP, BlackRock, Inc., RENAISSANCE TECHNOLOGIES LLC, Aberdeen Group plc, TWO SIGMA ADVISERS, LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA INVESTMENTS, LP, and DIMENSIONAL FUND ADVISORS LP. This page lists 121 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.